NLTX
Neoleukin Therapeutics, Inc.
No insider bought or sold Neoleukin Therapeutics, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
NLTX over the last year
Prices for NLTX aren't in yet.
NLTX after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
13 insider filings since 2019, newest first
NLTXBuy
Baker Bros. Advisors LP · Director and 10% owner
$1.5M+69.0%Aug 17
NLTXBuy
Jonathan G Drachman · President and CEO
$934K+7.0%Aug 26
NLTXBuy
Jonathan G Drachman · President and CEO
$475K+2.0%Jun 7
NLTXSell
Carl Walkey · SVP
$30KApr 30
NLTXSell
Carl Walkey · SVP
$29KMar 24
NLTXSell
Robert Ho · CFO
$72K−23.0%Mar 18
NLTXSell
Carl Walkey · SVP
$30KFeb 25
NLTXSell
Carl Walkey · SVP
$30KFeb 18
NLTXSell
Carl Walkey · SVP
$43KFeb 12
NLTXSell
Carl Walkey · SVP
$32KFeb 5
NLTXBuy
Baker Bros. Advisors LP · Director
$6.5M+14.0%Dec 23
NLTXSell
Redmile Group, LLC · 10% owner
$220KApr 6
NLTXBuy
Jonathan G Drachman · Insider
$782K+73.0%Sep 11
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.